Document:

EX-10.7

 Exhibit 10.7 

SHAREHOLDER AGREEMENT 

THIS SHAREHOLDER AGREEMENT (as amended, restated, supplemented or otherwise modified in
accordance with Section 10.3, this “Agreement”) is made and entered into as of May 5, 2021 by and between Aterian, Inc., a Delaware corporation (the “Company”), and Ran Nir (the
“Stockholder”). 
 RECITALS 

WHEREAS, pursuant to that certain Stock Purchase Agreement, dated as of even date herewith (the
“Purchase Agreement”), by and among the Company, Truweo, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Acquisition Sub”), the Stockholder, Josef Eitan and Photo Paper Direct
Ltd, a private limited company organized under the laws of England and Wales (“PPD”), the Company issued 176,137 shares of its common stock, $0.0001 par value per share (the “Common Stock”), to the Stockholder at
the closing of Acquisition Sub’s acquisition of 100% of the outstanding equity of PPD (such shares of Common Stock, the “Closing Securities”), for the benefit of the Stockholder thereunder; 

WHEREAS, the Company has agreed, subject to the terms and conditions of the Purchase Agreement, to issue
and deliver to the Stockholder additional shares of Common Stock as further consideration in the event that PPD achieves certain results of operations set forth in the Purchase Agreement during the 2021 calendar year (any such shares of Common
Stock, the “Earn-Out Securities,” and together with the Closing Securities, the “Securities”); 

WHEREAS, as a condition to entering into the Purchase Agreement, the Company has required that the
Stockholder enter into this Agreement, and the Stockholder, in order to induce the Company to enter into the Purchase Agreement, desires to enter into this Agreement. 

NOW, THEREFORE, in consideration of the foregoing premises and the
mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

AGREEMENT 
 1.
DEFINITIONS. 
 1.1 Defined Terms. As used in this Agreement, the following terms shall
have the following meanings: 
 (a) “Affiliate” and “Associate” shall have the respective
meanings ascribed to such terms in Rule 12b-2 of the General Rules and Regulations under the Exchange Act. 

(b) A Person shall be deemed the “Beneficial Owner” or to have “Beneficial Ownership” of
and shall be deemed to “beneficially own” any securities which such Person or any of such Person’s Affiliates or Associates is deemed to beneficially own, within the meaning of Rules 13d-3 and 13d-5 of the General Rules and Regulations under the Exchange Act. 
 Notwithstanding anything in this definition of
Beneficial Ownership to the contrary, the phrase, “then outstanding,” when used with reference to a Person’s Beneficial Ownership of securities of the Company, shall mean the number of such securities then issued and outstanding
together with the number of such securities not then actually issued and outstanding which such Person would be deemed the Beneficial Owner hereunder. 

  
 1. 

 (c) “Company Acquisition Transaction” shall mean (i) the
commencement (within the meaning of Rule 14d-2 of the General Rules and Regulations under the Exchange Act) of a tender or exchange offer by a third party for at least fifteen percent (15%) of the then
outstanding capital stock of the Company or any direct or indirect Subsidiary of the Company, (ii) the commencement by a third party of a proxy contest with respect to the election of any directors of the Company, (iii) any sale, license,
lease, exchange, transfer, disposition or acquisition of any portion of the business or assets of the Company or any direct or indirect Subsidiary of the Company (other than in the ordinary course of business), or (iv) any merger,
consolidation, business combination, share exchange, reorganization, recapitalization, restructuring, liquidation, dissolution or similar transaction or series of related transactions involving the Company or any direct or indirect Subsidiary of the
Company. 
 (d) “Group” shall have the meaning set forth in Section 13(d)(3) of the Exchange Act and Rule 13d-5 of the General Rules and Regulations under the Exchange Act. 
 (e) “Subject
Securities” means the Securities, including any equity securities issued or issuable directly or indirectly with respect to such Securities by way of any stock dividend or stock split or in connection with a combination of shares,
recapitalization, reclassification, merger, amalgamation, arrangement, consolidation or other reorganization. 
 (f)
“Subsidiary” of any Person shall mean any corporation or other entity of which a majority of the voting power of the voting equity securities or equity interest is owned, directly or indirectly, by such Person. 

(g) “Voting Securities” shall mean the shares of Common Stock; provided, however, that,
“Voting Securities,” when used in this Agreement in connection with a specific reference to any Person other than the Company, shall mean the capital stock (or equity interest) with the greatest voting power of such other Person or, if
such other Person is a Subsidiary of another Person, the Person or Persons which ultimately control such first-mentioned Person. 

1.2 Capitalized Terms. All other capitalized terms used herein but not defined shall have the meanings ascribed to such terms in
the Purchase Agreement. 
 2. MATERIAL NON-PUBLIC
INFORMATION; REPORTING OBLIGATIONS. 
 2.1 Stockholder acknowledges that it is aware,
and will advise each of its representatives who are informed as to the matters that are the subject of the Purchase Agreement and this Agreement, that the United States securities laws may prohibit any person who has received from an issuer
material, non-public information from purchasing or selling securities of such issuer or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that
such person is likely to purchase or sell such securities. 
 2.2 To the extent that Stockholder is required to do so by applicable
law as result of the transactions contemplated by the Purchase Agreement, Stockholder acknowledges and agrees that it shall: (a) be solely responsible for the filing of (i) any Forms 3, 4 and 5 in accordance with Section 16(a) of the
Exchange Act and the rules promulgated thereunder and (ii) any Schedule 13D or 13G, as applicable, under the Exchange Act and the rules promulgated thereunder, in each case, in respect of its ownership of a registered class of securities of the
Company, and (b) timely file such forms and schedules or amendments thereto with the SEC and any stock exchange or similar authority, as required. 

  
 2 

 3. STANDSTILL. 

3.1 Standstill Provisions. Commencing on the date of this Agreement and until the date that is the fifth (5th) anniversary of the date of this Agreement (the “Standstill Period”), the Stockholder agrees, on behalf of itself and its Affiliates and Associates, that for so long as such Persons
collectively Beneficially Own any Voting Securities, except pursuant to a negotiated transaction with the Stockholder approved by the board of directors of the Company (the “Board”), the Stockholder will not (and will cause its
Affiliates and Associates not to), in any manner, directly or indirectly: 
 (a) make, effect, initiate, cause or participate in
(i) any acquisition of Beneficial Ownership of any securities of the Company (other than as a result of the Company’s issuance of Earn-Out Securities to the Stockholder) or any securities of any
Subsidiary or other Affiliate or Associate of the Company if such acquisition would result in the Stockholder and its Affiliates and Associates collectively Beneficially Owning ten percent (10%) or more of the then outstanding Voting Securities,
(ii) any Company Acquisition Transaction, (iii) any “solicitation” of “proxies” (as those terms are defined in Rule 14a-1 of the General Rules and Regulations under the Exchange
Act) or consents with respect to any securities of the Company or (iv) frustrate or seek to frustrate any Company Acquisition Transaction proposed or endorsed by the Company; 

(b) recommend, nominate or seek to nominate any Person to the Board or otherwise act, alone or in concert with others, to seek to
control or influence the management, the Board or policies or governance of the Company; 
 (c) take any action which might force the
Company to make a public announcement regarding any of the types of matters set forth in subsection (a) of this Section 3.1; 

(d) request or propose that the Company (or its directors, officers, employees or agents), directly or indirectly, amend or waive any
provision of this Section 3.1, including this subsection (d); 
 (e) demand an inspection of the
Company’s books and records whether pursuant to Section 220 of the General Corporation Law of the State of Delaware or otherwise; 

(f) institute, solicit, assist or join any litigation, arbitration or other proceeding against or involving the Company or any of its
current or former directors or officers (including derivative actions) other than to enforce the provisions of this Agreement or any rights available to the Stockholder under the Purchase Agreement and the Transaction Documents; 

(g) agree or offer to take, or encourage or propose (publicly or otherwise) the taking of, any action referred to in subsections (a),
(b), (c), (d), (e) or (f) of this Section 3.1; 
 (h) assist, induce or encourage any other Person to
take any action referred to in subsections (a), (b), (c), (d), (e) or (f) of this Section 3.1; 
 (i)
enter into any discussions, negotiations, agreements, understandings or arrangements with any third party with respect to the taking of any action referred to in subsections (a), (b), (c), (d), (e) or (f) of this
Section 3.1; or 
 (j) take any action challenging the validity or enforceability of this
Section 3.1 of this Agreement unless the Company is challenging the validity or enforceability of this Agreement. 

  
 3 

 3.2 Termination of Standstill Provisions 

(a) Subject to Section 3.2(b), the provisions of Section 3.1 shall terminate and be
of no further force and effect in the event the Board shall have endorsed, approved, recommended, or resolved to endorse, approve or recommend a Company Acquisition Transaction. 

(b) All of the provisions of Section 3.1 shall be reinstated and shall apply in full force according to their
terms in the event that: (i) if the provisions of Section 3.1 shall have terminated as the result of a tender offer, and such tender offer (as originally made or as amended or modified) shall have terminated (without
closing) prior to the commencement of a tender offer by the Stockholder or any of its Affiliates or Associates that would have been permitted to be made pursuant to Section 3.2(a) as a result of such third-party tender
offer; (ii) any tender offer by the Stockholder or any of its Affiliates or Associates (as originally made or as extended or modified) that was permitted to be made pursuant to Section 3.2(a) shall have terminated
(without closing); or (iii) if the provisions of Section 3.1 shall have terminated as a result of any action by the Board referred to in Section 3.2(a), and the Board shall have determined not
to take any of such actions (and no such transaction considered by the Board shall have closed) prior to the commencement of a tender offer by the Stockholder that would have been permitted to be made pursuant to
Section 4.2(a) as a result of the initial determination of the Board referred to in Section 3.2(a). 

(c) Upon reinstatement of the provisions of Section 3.1, the provisions of this
Section 3.2 shall continue to govern for the remainder of the Standstill Period in the event that any of the events described in Section 3.2(a) shall occur. Upon the closing of any tender offer for
or acquisition of any securities of the Company or rights or options to acquire any such securities by the Stockholder or any of its Affiliates or Associates that would have been prohibited by the provisions of Section 3.1
but for the provisions of this Section 3.2, all provisions of Section 3.1 and Section 3.2 shall terminate. 

3.3 Sales of Shares of Common Stock. During the Standstill Period, the Stockholder will only sell shares of Common Stock in open
market transactions on The Nasdaq Stock Market, LLC or on such principal stock exchange as the Common Stock is then listed for trading or in private transactions so long as any sale in a private transaction is not to any Person or Group who the
Stockholder reasonably believes after due inquiry Beneficially Owns or as a result of such transaction would Beneficially Own more than five percent (5%) of the then outstanding Voting Securities. Upon sale by the Stockholder of any Common Stock
after the Standstill Period to any Person or Group that is not an Affiliate or Associate of the Stockholder, such Common Stock shall no longer be subject to the restrictions or provisions of this Agreement. 

4. REGISTRATION RIGHTS. 

4.1 Shelf Take-Down. The Company undertakes to use commercially reasonable efforts to register the Subject Securities as soon as
practicable following their issuance either through a Shelf Registration Statement or through a Piggy Back Registration Statement (each as defined below). After a Shelf Registration Statement becomes effective, if applicable, the Company shall
promptly notify the Stockholder after which the Stockholder may deliver a notice to the Company stating that the Stockholder intends to register all of the then outstanding Subject Securities on the Shelf Registration Statement (a “Shelf
Offering” and such notice, the “Shelf Take-Down Notice”). Upon receipt of the Shelf Take-Down Notice, the Company shall, subject to the other
applicable provisions of this Agreement, amend or supplement the applicable Shelf Registration Statement as may be necessary to enable the Subject Securities included in the Shelf Take-Down Notice to be sold and distributed pursuant to the Shelf
Offering; provided, however, that the Company will include in the Shelf Offering only such number of Subject Securities that can be sold without resulting in an Adverse Disclosure (as defined below). For the purposes of this
Section 4: (a) “Shelf Registration Statement” means a registration statement of the Company filed with the SEC on Form S-1 or
Form S-3 for an offering to be made on a continuous basis pursuant to Rule 415 under the 

  
 4 

 
Securities Act of 1933, as amended (the “Securities Act”), or any similar rule that may be adopted by the SEC, covering the Common Stock; and (b) “Adverse
Disclosure” means public disclosure of material non-public information that, in the good faith judgment of the Company (after consultation with legal counsel) (i) would be required to be made in
any registration statement filed with the SEC by the Company so that such registration statement would not be materially misleading and (ii) would not be required to be made at such time but for the filing, effectiveness or continued use of
such registration statement. 
 4.2 Piggyback Registration. 

(a) If the Company proposes to file a registration statement under the Securities Act with respect to an offering of Common Stock or
securities convertible into, or exchangeable or exercisable for, Common Stock, whether or not for sale for its own account (including a Shelf Registration Statement, but other than a registration statement (i) on Form S-4, Form S-8 or any successor forms thereto or (ii) filed to effectuate an exchange offer or any employee benefit or dividend reinvestment plan), in a manner that would
permit registration of the Subject Securities for sale for cash to the public under the Securities Act, then the Company shall give prompt written notice of such filing, which notice shall be given to the Stockholder no later than ten
(10) business days prior to the filing date (the “Piggyback Notice”). The Piggyback Notice shall offer the Stockholder the opportunity to include (or cause to be included) in such registration statement the number of shares of
Subject Securities as the Stockholder may request (each, a “Piggyback Registration Statement”). Subject to Section 4.2(b), the Company shall include in each Piggyback Registration Statement all Subject
Securities with respect to which the Company has received written requests for inclusion therein (each, a “Piggyback Request”) within five (5) business days after the date of the Piggyback Notice. The Company shall not be
required to maintain the effectiveness of a Piggyback Registration Statement beyond the earlier of (x) 120 days after the effective date thereof and (y) consummation of the distribution by the holders of the Subject Securities included in such
registration statement. The Company may withdraw a Piggyback Registration Statement at any time prior to any sales being made pursuant to the Piggyback Registration Statement without incurring any liability to the Stockholder. 

(b) If any of Subject Securities to be registered pursuant to the registration giving rise to the rights under this
Section 4.2 are to be sold in a registered offering in which securities of the Company are sold to one or more underwriters on a firm commitment basis for reoffering to the public (an “Underwritten
Offering”), the Company shall use commercially reasonable efforts to cause the managing underwriter or underwriters of a proposed Underwritten Offering to permit the Stockholder to include in such offering all Subject Securities included in
the Stockholder’s Piggyback Request on the same terms and subject to the same conditions as any other shares of capital stock, if any, of the Company included in the Underwritten Offering; provided that the Stockholder timely submits a
Piggyback request in connection with such offering. Notwithstanding the foregoing, if the managing underwriter or underwriters of such offering advise the Company in writing that in its or their good faith opinion the number of securities to be
registered exceeds the number of securities which can be sold in such offering in light of market conditions or will adversely affect the success of such offering, the Company will include in such Underwritten Offering only such number of securities
that can be sold without adversely affecting the marketability of the offering, which securities will be so included in the following order of priority: (i) first, the securities proposed to be sold by the Company for its own account and
(ii) second, the Subject Securities of the Stockholder and any other persons with piggyback registration rights who have the right to participate and that have requested to participate in such offering, allocated pro rata among
the selling shareholders according to the total amount of securities entitled to be included therein owned by each selling shareholder and its Affiliates (other than the Company) or in such other proportions as shall mutually be agreed to by such
selling shareholders. 

  
 5 

 (c) As to any particular Subject Securities, once issued, such securities shall cease
to be subject to this Section 4.2 when (i) such securities are sold or otherwise transferred pursuant to an effective registration statement under the Securities Act, (ii) such securities shall have ceased to be
outstanding, (iii) such securities have been transferred in a transaction in which the Stockholder’s rights under this Agreement are not assigned in accordance with the terms of this Agreement to the transferee of the securities,
(iv) such securities are sold in a broker’s transaction under circumstances in which all of the applicable conditions of Rule 144 promulgated under the Securities Act (or any similar provisions then in force) are met, or (v) as to any
Subject Securities that are Common Stock of the Stockholder, at any time the Stockholder and its affiliates own less than 1% of the outstanding shares of Common Stock. 

4.3 Suspension. The Company shall be entitled, by providing written notice to the Stockholder, no more than two (2) times in
any twelve (12) month period for a period of time not to exceed 90 days in the aggregate, to postpone the filing or effectiveness of a registration statement to sell Subject Securities or to require the Stockholder to suspend any offerings or
sales of Subject Securities pursuant to a registration statement in accordance with this Section 4 if the Company delivers to the Stockholder a certificate signed by an executive officer certifying that such registration
and offering would (a) require the Company to make an Adverse Disclosure or (b) materially interfere with any bona fide material financing, acquisition, disposition or other similar transaction involving the Company or any of its
Subsidiaries then under consideration. Such certificate shall contain a statement of the reasons for such suspension and an approximation of the anticipated length of such suspension, in accordance with the specifications set forth in this
Section 4.3. The Stockholder shall keep the information contained in such certificate confidential. 
 4.4
Expenses of Registration. All Registration Expenses (as defined below) incurred in connection with any registration pursuant to this Section 4 shall be borne by the Company. All (a) underwriting discounts,
selling commissions and stock transfer taxes applicable to the securities registered by the Stockholder, or (b) the fees and expenses of an auditor of the Stockholder or any counsel to the Stockholder incurred in connection with the sale of
Subject Securities by the Stockholder shall be borne by the Stockholder on a pro rata basis with any other holders included in such registration. “Registration Expenses” means all expenses incurred by the Company in complying
with this Section 4, including all registration, qualification, listing and filing fees, printing expenses, escrow fees, and fees and disbursements of counsel for the Company, fees and disbursements of the Company’s
independent public accountants, fees and disbursements of the transfer agent, blue sky fees and expenses. 
 4.5 Cooperation by the
Stockholder. If the Stockholder elects to register Subject Securities in accordance with Section 4.1 or Section 4.2, the Stockholder shall furnish to the Company the number of shares of Common
Stock owned by the Stockholder, the number of such Subject Securities proposed to be sold, as applicable, the name and address of the Stockholder, and the distribution proposed by the Stockholder as shall be required in connection with any
registration, qualification or compliance referred to in this Agreement. It is understood and agreed that the obligations of the Company under this Section 4 are conditioned on the timely provisions of the foregoing
information by the Stockholder and, without limitation of the foregoing, will be conditioned on compliance by the Stockholder with the following: (a) the Stockholder will cooperate with the Company in connection with the preparation of the
applicable registration statement and prospectus and, for so long as the Company is obligated to keep such registration statement effective, the Stockholder will provide to the Company, in writing and in a timely manner, for use in such registration
statement (and expressly identified in writing as such), all information regarding themselves and such other information as may be required by applicable law to enable the Company to prepare or amend such registration statement, any related
prospectus and any other documents related to such offering covering the applicable Subject Securities owned by the Stockholder and to maintain the currency and effectiveness thereof; and (b) during such time as the Stockholder may be engaged
in a distribution of Subject Securities, the Stockholder will comply with all laws applicable to such distribution, and will (i) not engage in any stabilization activity in connection with the securities of the Company in contravention of such
laws; (ii) distribute the Subject Securities solely in the manner described in the applicable registration statement and (iii) if required by applicable law, cause to be furnished to each agent or broker-dealer to or through whom such
Subject Securities may be offered, or to the offeree if an offer is made directly by the Stockholder, such copies of the applicable prospectus (as amended and supplemented to such date) and documents incorporated by reference therein as may be
required by such agent, broker-dealer or offeree. 

  
 6 

 5. VOTING OF STOCKHOLDER SHARES. 

5.1 Shares Held Subject to Agreement. Until the Termination Date, for so long as the Stockholder and its Affiliates and
Associates collectively Beneficially Own any Common Stock or any other Voting Securities, the Stockholder agrees to hold all such Common Stock or other Voting Securities registered in such Stockholder’s name or Beneficially Owned by such
Stockholder as of the date hereof and any and all other voting securities of the Company legally or beneficially acquired by them after the date hereof, including any Earn-Out Securities (hereinafter
collectively referred to as the “Stockholder Shares”) subject to, and to vote the Stockholder Shares in accordance with, the provisions of this Agreement. 

5.2 Vote Required. At all times prior to the Termination Date, the Stockholder shall timely vote in person or by proxy at each
annual or special meeting of the Company’s stockholders (or shall consent to vote pursuant to an action by written consent of the holders of capital stock of the Company, as and if permitted by the Company’s bylaws) all such Stockholder
Shares in accordance with the recommendations of the Board on each matter presented to the Company’s stockholders at such meeting or consent solicitation as set forth in the applicable definitive proxy statement, including without limitation
the election, removal and/or replacement of directors. 
 5.3 Irrevocable Proxy. The Stockholder hereby constitutes and
appoints the Company with full power of substitution, as the proxy of such stockholder with respect to all matters in accordance with Section 5, and hereby authorizes the Company to represent and to vote, if and only if
such stockholder: (a) fails to vote; or (b) attempts to vote (whether by proxy, in person or by written consent), in a manner which is inconsistent with the terms of this Agreement, all of the Stockholder Shares in accordance with the
recommendation of the Board on each matter presented to the Company’s stockholders at any annual or special meeting of the Company’s stockholders or consent solicitation, in each case, as required pursuant to the terms and provisions of
this Agreement. The proxy granted pursuant to the immediately preceding sentence is coupled with an interest and shall be irrevocable unless and until this Agreement terminates pursuant to Section 9 hereof. The Stockholder
hereby revokes any and all previous proxies with respect to the Stockholder Shares and shall not hereafter, unless and until this Agreement terminates pursuant to Section 9 hereof, purport to grant any other proxy or power
of attorney with respect to any of the Stockholder Shares, deposit any of such Stockholder Shares into a voting trust or enter into any agreement (other than this Agreement), arrangement or understanding with any Person, directly or indirectly, to
vote, grant any proxy or give instructions with respect to the voting of any of such Stockholder Shares, in each case, with respect to any matter presented to the Company’s stockholders for approval at any annual or special meeting of the
Company’s stockholders or written consent. 
 6. REPRESENTATIONS AND WARRANTIES. 

6.1 Each party hereto represents and warrants to the other as follows: 

(a) Authorization. Such party has the requisite power, authority and legal capacity to execute, deliver and perform and to
consummate the transactions contemplated by this Agreement. This Agreement constitutes a legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms, except as such enforcement may be limited by any
applicable bankruptcy, insolvency, moratorium or similar law affecting creditors’ rights generally. 

  
 7 

 (b) No Consents. No consent of any Governmental Authority or other Person is
required to be obtained by such party in connection with the execution and delivery by such party of this Agreement. 
 6.2 The
Stockholder represents and warrants to the Company that as of the date hereof, the Stockholder and its Affiliates and Associates collectively Beneficially Own 176,137 shares of Common Stock and have no other interest in the capital stock of the
Company other than the right to receive the Earn-Out Securities subject to the terms and conditions of the Purchase Agreement. 

6.3 The Stockholder understands and acknowledges that the Company is entering into the Purchase Agreement in reliance upon the
Stockholder’s execution, delivery and performance of this Agreement. 
 7. LEGEND. 

7.1 Concurrently with the execution of this Agreement, and in addition to any other legends provided for in the Purchase Agreement,
there shall be imprinted or otherwise placed on the book-entry statements representing the Stockholder Shares the following restrictive legend (the “Legend”): 

“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF A SHAREHOLDER AGREEMENT WHICH PLACES CERTAIN
RESTRICTIONS ON THE TRANSFER AND VOTING OF THE SHARES REPRESENTED HEREBY. ANY PERSON ACCEPTING ANY INTEREST IN SUCH SHARES SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL THE PROVISIONS OF SUCH AGREEMENT. A COPY OF SUCH SHAREHOLDER
AGREEMENT WILL BE FURNISHED TO THE RECORD HOLDER OF THIS CERTIFICATE WITHOUT CHARGE UPON WRITTEN REQUEST TO THE COMPANY AT ITS PRINCIPAL PLACE OF BUSINESS.” 

7.2 Subject to a sale to a third party pursuant to Section 3.3, above, the Stockholder agrees that, during the
term of this Agreement, it will not remove, and will not permit to be removed (upon registration of transfer, reissuance of otherwise), the Legend from any such book-entry statements and will place or cause to be placed the Legend on any new
book-entry statements issued to represent Stockholder Shares theretofore represented by a book-entry statements carrying the Legend. The Stockholder will not request that any of the Stockholder Shares be converted from book-entry format to
certificated shares. 
 8. SUCCESSORS. During the Standstill Period, the provisions of this
Agreement shall be binding upon the successors in interest to any of the Stockholder Shares. During the Standstill Period, the Company shall not permit the transfer of any of the Stockholder Shares on its books or issue a new certificate
representing any of the Stockholder Shares unless and until the successors in interest to whom such security is to be transferred shall have executed a written agreement, substantially in the form of this Agreement, pursuant to which such successors
in interest becomes a party to this Agreement and agrees to be bound by all the provisions hereof as if such Person were a Stockholder hereunder. A purchaser in an open market transaction shall not be deemed a successor in interest. 

9. TERMINATION. This Agreement shall continue in full force and effect from the date hereof
through the earliest of the following dates, on which date (the “Termination Date”) it shall terminate in its entirety on the earlier of: (a) the date that is the fifth (5th) anniversary of the date of this Agreement and (b) the date of the closing of a sale, lease, or other disposition of all or substantially all of the Company’s assets or the Company’s
merger into or consolidation with any other corporation or other entity, or any other corporate reorganization, in which the holders of the Company’s outstanding voting stock immediately prior to such

  
 8 

 
transaction own, immediately after such transaction, securities representing less than 50% of the voting power of the corporation or other entity surviving such transaction; provided,
however, that this clause “(b)” shall not apply to a merger effected exclusively for the purpose of changing the domicile of the Company; and (c) the date as of which this Agreement is terminated by the written consent
of the Company and the Stockholder. 
 10. MISCELLANEOUS. 

10.1 Specific Performance. The parties hereto agree that irreparable damage would occur in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, each of the parties hereto shall be entitled to enforce specifically the provisions of this Agreement, including obtaining an
injunction or injunctions to prevent breaches or threatened breaches of this Agreement, in any court designated to resolve disputes concerning this Agreement (or, if such court lacks subject matter jurisdiction, in any appropriate state or federal
court), this being in addition to any other remedy to which such party is entitled at law or in equity. Each party hereto further agrees not to assert and waives (a) any defense in any action for specific performance that a remedy at law would
be adequate and (b) any requirement under any law to post security or provide indemnity as a prerequisite to obtaining equitable relief. 

10.2 Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing
party hereto shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.  

10.3 Amendment and Waiver. Any provision of this Agreement may be amended and the observance thereof may be waived (either
generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Stockholder. No failure or delay of any party hereto to exercise any right or remedy given to such party under this
Agreement or otherwise available to such party or to insist upon strict compliance by any other party with its obligations hereunder and no single or partial exercise of any such right or power shall constitute a waiver of any party hereto’s
right to demand exact compliance with the terms hereof. Any written waiver shall be limited to those items specifically waived therein and shall not be deemed to waive any future breaches or violations or other
non-specified breaches or violations unless, and to the extent, expressly set forth therein. 

10.4 Notices. All notices and other communications made pursuant to or under this Agreement shall be given pursuant to the terms
of the notice provisions in Section 9.01 of the Purchase Agreement. 
 10.5 Severability. If any term
or provision of this Agreement is held invalid, illegal or unenforceable in any respect under any applicable law, the validity, legality and enforceability of all other terms and provisions of this Agreement will not in any way be affected or
impaired. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely
as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement be consummated as originally contemplated to the greatest extent possible. 

10.6 Governing Law. This Agreement shall be construed and enforced in accordance with, and all questions concerning the
construction, validity, interpretation, inducement to enter and/or performance of this Agreement (whether related to breach of contract, tortious conduct or otherwise and whether now existing or hereafter arising) shall be governed by, the internal
laws of the State of Delaware, without giving effect to any law that would cause the laws of any jurisdiction other than the State of Delaware to be applied. 

  
 9 

 10.7 Consent to Jurisdiction; Service of Process; Waiver of Jury Trial. 

(a) Each Party agrees that any proceeding arising out of or relating to this Agreement or any transaction contemplated hereby shall be
brought exclusively in any state or federal court located in New York County, State of New York, and each of the Parties hereby submits to the exclusive jurisdiction of such courts for itself and with respect to its property, generally and
unconditionally, for the purpose of any such proceeding. A final judgment in any such proceeding may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Each Party agrees not to commence any proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby except in the courts described above (other than actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court
in New York as described above), irrevocably and unconditionally waives any objection to the laying of venue of any proceeding arising out of or relating to this Agreement or the transactions contemplated hereby in any such court, and hereby
irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such proceeding brought in any such court has been brought in an inconvenient forum or does not have jurisdiction over any Party. Each Party agrees
that service of any process, summons, notice or document by U.S. registered mail to such Party’s respective address set forth in the Purchase Agreement shall be effective service of process for any such proceeding. 

(b) EACH PARTY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT,
STATUTE OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF SUCH PARTY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF. EACH PARTY FURTHER WAIVES ANY RIGHT TO SEEK TO CONSOLIDATE ANY PROCEEDING IN
WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER PROCEEDING IN WHICH A JURY TRIAL CANNOT OR HAS NOT BEEN WAIVED. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED OR
WARRANTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (III) EACH PARTY MAKES
THIS WAIVER VOLUNTARILY AND (IV) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 10.7. 

10.8 Entire Agreement. Except for the Purchase Agreement, this Agreement sets forth the entire understanding and agreement
between the parties hereto with respect to the subject matter hereof. 
 10.9 Counterparts. This Agreement may be executed in
multiple counterparts, each of which shall be deemed to be an original but all of which shall constitute one and the same agreement. This Agreement may be executed by facsimile or electronic (.pdf) signature and a facsimile or electronic (.pdf)
signature shall constitute an original for all purposes. 
 [The remainder of this page is intentionally left blank.] 

  
 10 

 IN WITNESS WHEREOF, the
parties hereto have executed this SHAREHOLDER AGREEMENT as of the date first written above. 
  

					
	COMPANY: 	 		 	STOCKHOLDER:
			
	ATERIAN, INC.	 		 	RAN NIR
			
	 /s/ Yaniv Sarig
	 		 	 /s/ Ran Nir

	Yaniv Sarig	 		 	
	CEO	 		 	

 (Signature Page to Shareholder Agreement)EX-10.1

 Exhibit 10.1 
  

 
 May 10, 2021 
 Tom
Castellano 
 [Address on file with Company] 
 USA 

Dear Tom: 
 Congratulations on your promotion to Senior Vice
President & Chief Financial Officer (SVP CFO). This letter amends and restates previous offer letters and is effective June 1, 2021. 
 The
following is important information about your new position, benefits and rewards. I encourage you to review all materials thoroughly and contact me with questions. 

1. Position: Your position is SVP CFO, reporting directly to John Chiminski, Chair and CEO, Catalent, Inc. As SVP CFO, you will continue as a member of
Catalent’s Executive Leadership Team (ELT). 
 2. Pay: Your annualized base pay is $500,000. and paid
bi-weekly. As a member of our ELT, your salary will be reviewed annually and adjusted if required based on market data. 

3. Performance: Your performance reviews follow the standard annual review calendar for Catalent. Annual Goal and Objectives will be set and amended by
the CEO as appropriate. 
 4. Rewards: Catalent is pleased to offer a comprehensive, competitive compensation program that rewards talented employees
for their performance. 
 a. You will continue to be eligible for participation in our short-term incentive plan, “Management Incentive
Plan” (MIP). Your annual target incentive has increased to $400,000 effective July 1, 2021. Your actual MIP dollar value target will be reviewed annually and adjusted in the sole discretion of the company following a review of market data.
Actual annual bonus payments are determined based upon the achievement of specific financial and management agenda objectives and your achievement of your personal goals and objectives. 

b. You will continue to be eligible for participation in our Long-Term Incentive Plan (LTIP). Your target LTIP grant value will be $600,000.
Your new LTIP target will be effective with the FY22-FY24 LTIP award scheduled to be granted in July 2021. Components of the award are proportionately 50% performance share units (PSUs), 30% stock options and 20% restricted stock units (RSUs), all
to be granted in accordance with Catalent’s normal practices for LTlP awards to ELT members, which includes your execution of agreements with respect to each grant. Your LTIP annual grant value as well as the component mix will be reviewed
annually and adjusted in the sole discretion of the company following a review of market data. 
 5. Severance: Your original separate severance
agreement letter that provides you severance equal to your annual base salary and target annual MIP will continue, subject to the terms and conditions of the severance agreement. 

 6. Paid Time Off: You remain eligible for our eight (8) paid company holidays (New Year’s
Day, Martin Luther King Day, Memorial Day, Independence Day, Labor Day, Thanksgiving Day and the day following, and Christmas Day). You are also eligible to receive up to 31 days of Paid Time Off (PTO) each calendar year. PTO includes vacation, sick
and personal days, all of which need to be used during the calendar year as we do not permit carry over, unless required by the laws of the place where you are based. 

7. Terms: Notwithstanding anything to the contrary in this offer letter, employment with Catalent is not for any definite period and is terminable,
with or without notice, at the will of either you or the company at any time for any reason. There shall be no contract, express or implied, of employment. 

8. Confidentiality: In accepting this offer, you reaffirm your commitment and understanding that you continue to be bound by the Confidentiality and Non-Compete terms set out in previous LTlP grants made to you. 
 9. Ethics: As a company founded on a core set of
values, we expect you to continue to abide by and certify, as may be requested from time to time, your continued compliance with our Standards of Business Conduct. 

Your agreement to the terms of this letter supersedes any other oral or written agreement or understanding you have with the company (including any prior
offer letter with the company or any predecessor entity) regarding your eligibility for rewards and benefits. 
 Please sign below to indicate your
agreement to the terms of this letter. 
 If you have any questions, please feel free to call me at 732-537-6147 or Ricardo Pravda at 732-537-5909. 

Sincerely yours, 
 /s/ John Chiminski 

John Chiminski 
 Chief Executive Officer 

Catalent Pharma Solutions, Inc. 
  

			
	cc:	  	Steven Fasman
		  	Ricardo Pravda

 I accept employment on the terms offered above: 
  

			
	 /s/ Tom Castellano
	  	 5/10/2021

	Tom Castellano	  	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}]]